A former employee of Stanford University was found guilty of accessing a clinical research database for a multisite breast ...
The addition of brentuximab vedotin to lenalidomide and rituximab extended survival among heavily pretreated patients with ...
Roche's drug portfolio shows promise, but mixed indicators reveal uncertainties. Check out the risks, opportunities, and ...
A jury found Naheed Mangi replaced patient medical data with erroneous information, insults about former boss.
A former employee of Stanford University was found guilty of accessing a clinical research database for a multisite breast ...
A jury found Naheed Mangi replaced patient medical data with erroneous information, insults about former boss.
Naheed Mangi, a former Stanford coordinator, was found guilty of tampering with a breast cancer study database.
Jay Cross, proven financial leader, appointed as CFO to drive strategic growth –– Faraz Siddiqui, expert in manufacturing operations, joins as ...
Pharmalittle: We’re reading about Zepbound price and dose changes, compounders suing FDA, and more
Eli Lilly will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells ...
With access to major transportation hubs like Philadelphia International Airport and the Amtrak Northeast Corridor, the city provides direct connections to other life sciences communities such as ...
The leading Cutaneous Squamous Cell Carcinoma Companies such as Incyte Corporation, Shanghai Henlius Biotech, Novartis, ...
Last year marked an all-time record of 18 Food and Drug Administration (FDA) biosimilar approvals, bringing the total number ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback